Genetic 'fingerprint' may ID breast cancer patients likely to benefit from potentially toxic chemo, study finds

A genetic ‘fingerprint’ may ID breast cancer patients likely to benefit from potentially toxic chemo, a Standford Medicine study finds. Conversely, these drugs could be avoided if it was known a patient was unlikely to benefit from their use.

If you would like to read more about this study, click the link below:

http://med.stanford.edu/news/all-news/2019/11/genetic-_fingerprint-may-id-breast-cancer-patients-likely-to-ben.html?fbclid=IwAR2WwjX6SzgZCBkIdO999FPMBM92bUuHyBbMhwWf5nySznZTw4DNqCUusK4

Share This Article

Breast Cancer Ireland

Lower Ground Floor
Breast Cancer Ireland
77 Merrion Square South
Dublin 2

Email: info@breastcancerireland.com
Tel: 00353-1-5160331

Charity No: Chy 19926

Breast Cancer Ireland has been incorporated as Breast Cancer Ireland CLG, trading as: Breast Cancer Ireland

X